Royalty Pharma (RPRX)
undefined
undefined%
At close: undefined
26.10
1.40%
After-hours Jan 06, 2025, 05:05 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Cash & Equivalents 477.01M 1.71B 1.54B 1.01B 283.68M 1.92B 1.38B 1.67B 1.72B
Short-Term Investments 18.30M 717.04M 1.26B 983.00M 509.53M 461.82M n/a n/a n/a
Long-Term Investments 1.01B 14.23B 14.63B 13.27B 11.48B 8.67B n/a n/a n/a
Other Long-Term Assets 14.09B 15.13M 4.14M 28.60M 87.95M 19.11M n/a n/a 822.28M
Receivables 775.09M 727.92M 682.66M 626.36M 491.33M 660.45M n/a n/a n/a
Inventory n/a 1.00 1.00 657.14M n/a 19.20M n/a n/a n/a
Other Current Assets 3.80M 90.52M 6.63M 8.60M 92.00K -14.50M 1.57B 1.33B 1.32B
Total Current Assets 1.27B 2.55B 2.88B 2.70B 832.07M 2.61B 2.95B 3.00B 3.04B
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles 1.78M 14.50M 5.67M 28.67M 51.72M 75.65M n/a n/a 6.95B
Total Long-Term Assets 15.11B 14.26B 14.64B 13.32B 11.62B 8.76B 8.43B 7.48B 7.77B
Total Assets 16.38B 16.81B 17.52B 21.10B 12.45B 11.37B 11.37B 10.48B 10.82B
Account Payables 15.16M 7.91M 5.62M 10.78M 11.18M 4.48M n/a n/a n/a
Deferred Revenue n/a n/a n/a n/a 31.04M n/a n/a n/a n/a
Short-Term Debt n/a 997.51M n/a n/a 281.98M 281.44M 280.93M 172.68M 184.38M
Other Current Liabilities 146.21M 161.37M 165.63M 297.11M 40.26M 294.26M 102.48M 124.63M 130.01M
Total Current Liabilities 161.38M 1.17B 171.25M 307.89M 333.42M 580.17M 383.41M 297.32M 314.39M
Long-Term Debt 6.14B 6.12B 7.10B 5.82B 5.96B 6.24B 6.52B 5.72B 5.80B
Other Long-Term Liabilities 900.00K 2.50M n/a n/a 18.90M n/a n/a n/a n/a
Total Long-Term Liabilities 6.14B 6.12B 7.10B 5.82B 5.98B 6.24B 6.52B 5.72B 5.80B
Total Liabilities 6.30B 7.29B 7.27B 6.12B 6.31B 6.82B 6.90B 6.02B 6.12B
Total Debt 6.14B 7.12B 7.10B 5.82B 6.24B 6.52B 6.80B 5.90B 5.99B
Common Stock 45.00K 107.00K 106.00K 102.00K 3.28B 3.28B n/a n/a n/a
Retained Earnings 2.52B 1.96B 2.26B 1.92B 2.83B 1.22B n/a n/a n/a
Comprehensive Income n/a 63.00K 16.49M 34.40M 2.09M -10.26M n/a n/a n/a
Shareholders Equity 6.53B 5.63B 5.78B 9.90B 6.11B 4.49B 4.46B 4.45B 4.68B
Total Investments 1.03B 533.94M 15.89B 14.25B 11.99B 605.42M n/a n/a n/a